Aspheric IOLs perform better than spherical IOLs

Article

Aspheric intraocular lenses induce less wavefront aberrations and perform better in photopic and mesopic conditions than spherical IOLs.

Aspheric intraocular lenses (IOLs) induce less wavefront aberrations and perform better in photopic and mesopic conditions than spherical IOLs, according to a report published in the September issue of Journal of Refractive Surgery.

Aldo Caporossi and co-workers from the University of Siena, Italy conducted a prospective, comparative, randomized study of 250 eyes of 125 subjects with bilateral cataracts. Patients were randomly assigned to receive either a spherical biconvex optic (AcrySof SN60AT [Alcon] or Sensar AR40e [AMO]) or an aspheric optic (AcrySof IQ SN60WF [Alcon], Tecnis Z9000 [AMO] or SofPort L161AO [Bausch & Lomb]).

Aspheric IOLs demonstrated better contract sensitivity compared with spherical IOLs at spatial frequencies of six, 12 and 18 cycles per degree under photopic conditions and at all spatial frequencies under mesopic conditions. There were no significant differences between the aspheric IOLs at all spatial frequencies under either photopic or mesopic conditions. Mean total spherical aberration was statistically lower in dominant eyes with aspheric IOLs compared with eyes with spherical IOLs for a 5 mm pupil diameter.

The results of this comparative study confirm that it is possible to improve the optical performance of IOLs by modifying the surfaces.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.